LOTEMAX
Generic: LOTEPREDNOL ETABONATE
Bausch & Lomb IncorporatedManufacturer
OPHTHALMICRoute
LOTEPREDNOL ETABONATEActive Substance
2011-04-15Original Approval
LOTEMAX is FDA application NDA200738, sponsored by BAUSCH AND LOMB. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
EYE PAIN
620 reports
2
EYE IRRITATION
509 reports
3
OFF LABEL USE
367 reports
4
VISION BLURRED
356 reports
5
DRUG INEFFECTIVE
337 reports
6
OCULAR HYPERAEMIA
290 reports
7
HEADACHE
240 reports
8
FATIGUE
218 reports
9
DRY EYE
190 reports
10
NAUSEA
176 reports